Abbott boosts dividends and highlights steady growth, reflecting strong shareholder return policies and financial health.

Abbott Laboratories closed $6.14 below its 52-week high ($121.64), which the company achieved on March 8th.

Abbott Laboratories closed $6.74 below its 52-week high ($121.64), which the company achieved on March 8th.

Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

Abbott (ABT) announced that its board of directors has increased the company’s quarterly common dividend to 59c per share, an increase of 7.3%.

We recently compiled a list of the 8 Best Dividend Kings To Invest In For Safe Dividend Growth. In this article, we are going ...

Abbott Laboratories (ABT) stock saw a decline, ending the day at $113.86 which represents a decrease of $-0.28 or -0.25% from the prior close of $114.14. The stock opened at $114.31 and touched a low ...

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and ...

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, ...

Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $115.6 which represents a slight increase of $0.01 or 0.01% from the prior close of $115.59. The stock opened at $115.13 and ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...